Immunologic derangement preceding clinical autoimmunity

Lupus

Volumn 23, Issue 12, 2014, Pages 1305-1308

  Dellavance, A ^a   Coelho Andrade, L E ^b  

^a Fleury   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

autoantibodies; autoimmune diseases; Autoimmunity; immunological tolerance; mechanisms of disease

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; EPITOPE; IMMUNOGLOBULIN CLASS; BIOLOGICAL MARKER;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONFERENCE PAPER; DISEASE COURSE; EARLY INTERVENTION; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGIC DERANGEMENT; IMMUNOPATHOLOGY; ONSET AGE; BLOOD; IMMUNOLOGY; MITOCHONDRION;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BIOLOGICAL MARKERS; HUMANS; MITOCHONDRIA;

EID: 84908662406     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314531346     Document Type: Conference Paper

References (38)

1. Tan EM. Autoantibodies to nuclear antigens (ANA): Their immunobiology and medicine. Adv Immunol. 1982 ; 33: 167-240
2. Waaler E. On the occurrence of a factor in human serum activating the specific agglutination of sheep corpuscles. Acta Pathol Microbiol Scand. 1940 ; 17: 172-188
3. Hargraves M, Richmond H, Morton R. Presentation of two bone marrow components, the tart cell and the LE cell. Mayo Clin Proc. 1948 ; 23: 25-28
4. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
5. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010 ; 69: 1580-1588
6. Aletaha D, Neogi T, Silman A, et al. 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010 ; 62: 2569-2581
7. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. J Hepatol. 2009 ; 51: 237-267
8. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology. 2009 ; 50: 291-308
9. Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010 ; 51: 1-31
10. Gómez-Puerta JA, Cervera R. Diagnosis and classification of the antiphospholipid syndrome. J Autoimmun. 2014 ; 48-49: 20-25
11. Shiboski SC, Shiboski CH, Criswell L, et al. American College of Rheumatology classification criteria for Sjögren's syndrome: A data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012 ; 64: 475-487
12. Mariz HA, Sato EI, Barbosa SH, Rodrigues SH, Dellavance A, Andrade LE. Pattern on the antinuclear antibody-HEp-2 test is critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum. 2011 ; 63: 191-200
13. Aho K, von Essen R, Kurki P, Palosuo T, Heliövaara M. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. J Rheumatol. 1993 ; 20: 1278-1281
14. Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis Rheum. 2004 ; 50: 380-386
15. Majka DS, Deane KD, Parrish LA, et al. Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis. Ann Rheum Dis. 2008 ; 67: 801-807
16. van de Stadt LA, van der Horst AR, de Koning MH, et al. The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia. Ann Rheum Dis. 2011 ; 70: 128-133
17. Aho K, Palosuo T, Knekt P, Alha P, Aromaa A, Heliövaara M. Serum C-reactive protein does not predict rheumatoid arthritis. J Rheumatol. 2000 ; 27: 1136-1138
18. Jørgensen KT, Wiik A, Pedersen M, et al. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: Case-control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis. 2008 ; 67: 860-866
19. Dean BM, Becker F, McNally JM, et al. Insulin autoantibodies in the pre-diabetic period: Correlation with the islet cell antibodies and development of diabetes. Diabetologia. 1986 ; 29: 339-342
20. Hummel M, Bonifacio E, Schmid S, Walter M, Knopff A, Ziegler AG. Brief communication: Early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Intern Med. 2004 ; 140: 882-886
21. Winter WE, Schatz DA. Autoimmune markers in diabetes. Clin Chem. 2011 ; 57: 168-175
22. Watanabe M, Iwatani Y, Kashiwai T, Iijima T, Fujikado T, Amino N. Euthyroid Graves'disease showing no thyroid abnormalities except positive thyroid-stimulating antibody (TSAb): Two case reports. J Intern Med. 1995 ; 238: 379-384
23. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med. 1996 ; 335: 99-107
24. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003 ; 349: 1526-1533
25. Israeli E, Grotto I, Gilburd B, et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut. 2005 ; 54: 1232-1236
26. Crosignani A, Battezzati PM, Invernizzi P, Selmi C, Prina E, Podda M. Clinical features and management of primary biliary cirrhosis. World J Gastroenterol. 2008 ; 14: 3313-3327
27. Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet. 2003 ; 362: 53-61
28. Dellavance A, Cançado EL, Abrantes-Lemos CP, Harriz M, Marvulle V, Andrade LE. Humoral autoimmune response heterogeneity in the spectrum of primary biliary cirrhosis. Hepatol Int. 2012 ; 7: 775-784
29. Sokolove J, Bromberg R, Deane KD, et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One. 2012 ; 7: e35296 - e35296
30. Battezzati PM, Podda M, Bianchi FB, et al. Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBC. J Hepatol. 1993 ; 17: 332-338
31. Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, James OF. Natural history of early primary biliary cirrhosis. Lancet. 1996 ; 348: 1399-1402
32. Lee YM, Kaplan MM. The natural history of PBC: Has it changed?. Semin Liver Dis. 2005 ; 25: 321-326
33. James JA, Kim-Howard XR, Bruner BF, et al. Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus. Lupus. 2007 ; 16: 401-409
34. Erkan D, Yazici Y, Peterson MG, Sammaritano L, Lockshin MD. A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford). 2002 ; 41: 924-929
35. El-Gabalawy HS, Robinson DB, Hart D, et al. Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American Native population with rheumatoid arthritis and their first-degree relatives. J Rheumatol. 2009 ; 36: 1130-1135
36. Kolfenbach JR, Deane KD, Derber LA, et al. Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis. Arthritis Rheum. 2010 ; 62: 2633-2639
37. Firestein GS, Zvaifler NJ. Anticytokine therapy in rheumatoid arthritis. N Engl J Med. 1997 ; 337: 195-197
38. Faleo G, Fotino C, Bocca N, et al. Prevention of autoimmune diabetes and induction of β-cell proliferation in NOD mice by hyperbaric oxygen therapy. Diabetes. 2012 ; 61: 1769-1778